SonoThera™ Completes $60.75M Series A Funding for Ultrasound-Guided, Nonviral Gene Therapy Platform Development
Lead investor ARCH Venture Partners is joined by Illumina Ventures, Johnson & Johnson Innovation – JJDC, Inc., Vertex Ventures HC, Medical Excellence Capital and others in global biotechnology and pharmaceutical investment. Funding will support platform optimization, preclinical development, early manufacturing, and initial proof of concept in humans. SonoThera’s technology platform and treatments aim to overcome […]
